Cargando…
Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) driven by oncogenic K-Ras remains among the most lethal human cancers despite recent advances in modern medicine. The pathogenesis of PDAC is partly attributable to intrinsic chromosome instability and extrinsic inflammation activation. However, the molecular...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518983/ https://www.ncbi.nlm.nih.gov/pubmed/28374746 http://dx.doi.org/10.1038/cr.2017.51 |
_version_ | 1783251561169813504 |
---|---|
author | Kang, Rui Xie, Yangchun Zhang, Qiuhong Hou, Wen Jiang, Qingping Zhu, Shan Liu, Jinbao Zeng, Dexing Wang, Haichao Bartlett, David L Billiar, Timothy R Zeh, Herbert J Lotze, Michael T Tang, Daolin |
author_facet | Kang, Rui Xie, Yangchun Zhang, Qiuhong Hou, Wen Jiang, Qingping Zhu, Shan Liu, Jinbao Zeng, Dexing Wang, Haichao Bartlett, David L Billiar, Timothy R Zeh, Herbert J Lotze, Michael T Tang, Daolin |
author_sort | Kang, Rui |
collection | PubMed |
description | Pancreatic ductal adenocarcinoma (PDAC) driven by oncogenic K-Ras remains among the most lethal human cancers despite recent advances in modern medicine. The pathogenesis of PDAC is partly attributable to intrinsic chromosome instability and extrinsic inflammation activation. However, the molecular link between these two events in pancreatic tumorigenesis has not yet been fully established. Here, we show that intracellular high mobility group box 1 (HMGB1) remarkably suppresses oncogenic K-Ras-driven pancreatic tumorigenesis by inhibiting chromosome instability-mediated pro-inflammatory nucleosome release. Conditional genetic ablation of either single or both alleles of HMGB1 in the pancreas renders mice extremely sensitive to oncogenic K-Ras-driven initiation of precursor lesions at birth, including pancreatic intraepithelial neoplasms, intraductal papillary mucinous neoplasms, and mucinous cystic neoplasms. Loss of HMGB1 in the pancreas is associated with oxidative DNA damage and chromosomal instability characterized by chromosome rearrangements and telomere abnormalities. These lead to inflammatory nucleosome release and propagate K-Ras-driven pancreatic tumorigenesis. Extracellular nucleosomes promote interleukin 6 (IL-6) secretion by infiltrating macrophages/neutrophils and enhance oncogenic K-Ras signaling activation in pancreatic lesions. Neutralizing antibodies to IL-6 or histone H3 or knockout of the receptor for advanced glycation end products all limit K-Ras signaling activation, prevent cancer development and metastasis/invasion, and prolong animal survival in Pdx1-Cre;K-Ras(G12D/+);Hmgb1(−/−) mice. Pharmacological inhibition of HMGB1 loss by glycyrrhizin limits oncogenic K-Ras-driven tumorigenesis in mice under inflammatory conditions. Diminished nuclear and total cellular expression of HMGB1 in PDAC patients correlates with poor overall survival, supporting intracellular HMGB1 as a novel tumor suppressor with prognostic and therapeutic relevance in PDAC. |
format | Online Article Text |
id | pubmed-5518983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-55189832017-09-18 Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer Kang, Rui Xie, Yangchun Zhang, Qiuhong Hou, Wen Jiang, Qingping Zhu, Shan Liu, Jinbao Zeng, Dexing Wang, Haichao Bartlett, David L Billiar, Timothy R Zeh, Herbert J Lotze, Michael T Tang, Daolin Cell Res Original Article Pancreatic ductal adenocarcinoma (PDAC) driven by oncogenic K-Ras remains among the most lethal human cancers despite recent advances in modern medicine. The pathogenesis of PDAC is partly attributable to intrinsic chromosome instability and extrinsic inflammation activation. However, the molecular link between these two events in pancreatic tumorigenesis has not yet been fully established. Here, we show that intracellular high mobility group box 1 (HMGB1) remarkably suppresses oncogenic K-Ras-driven pancreatic tumorigenesis by inhibiting chromosome instability-mediated pro-inflammatory nucleosome release. Conditional genetic ablation of either single or both alleles of HMGB1 in the pancreas renders mice extremely sensitive to oncogenic K-Ras-driven initiation of precursor lesions at birth, including pancreatic intraepithelial neoplasms, intraductal papillary mucinous neoplasms, and mucinous cystic neoplasms. Loss of HMGB1 in the pancreas is associated with oxidative DNA damage and chromosomal instability characterized by chromosome rearrangements and telomere abnormalities. These lead to inflammatory nucleosome release and propagate K-Ras-driven pancreatic tumorigenesis. Extracellular nucleosomes promote interleukin 6 (IL-6) secretion by infiltrating macrophages/neutrophils and enhance oncogenic K-Ras signaling activation in pancreatic lesions. Neutralizing antibodies to IL-6 or histone H3 or knockout of the receptor for advanced glycation end products all limit K-Ras signaling activation, prevent cancer development and metastasis/invasion, and prolong animal survival in Pdx1-Cre;K-Ras(G12D/+);Hmgb1(−/−) mice. Pharmacological inhibition of HMGB1 loss by glycyrrhizin limits oncogenic K-Ras-driven tumorigenesis in mice under inflammatory conditions. Diminished nuclear and total cellular expression of HMGB1 in PDAC patients correlates with poor overall survival, supporting intracellular HMGB1 as a novel tumor suppressor with prognostic and therapeutic relevance in PDAC. Nature Publishing Group 2017-07 2017-04-04 /pmc/articles/PMC5518983/ /pubmed/28374746 http://dx.doi.org/10.1038/cr.2017.51 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Original Article Kang, Rui Xie, Yangchun Zhang, Qiuhong Hou, Wen Jiang, Qingping Zhu, Shan Liu, Jinbao Zeng, Dexing Wang, Haichao Bartlett, David L Billiar, Timothy R Zeh, Herbert J Lotze, Michael T Tang, Daolin Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer |
title | Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer |
title_full | Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer |
title_fullStr | Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer |
title_full_unstemmed | Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer |
title_short | Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer |
title_sort | intracellular hmgb1 as a novel tumor suppressor of pancreatic cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518983/ https://www.ncbi.nlm.nih.gov/pubmed/28374746 http://dx.doi.org/10.1038/cr.2017.51 |
work_keys_str_mv | AT kangrui intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT xieyangchun intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT zhangqiuhong intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT houwen intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT jiangqingping intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT zhushan intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT liujinbao intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT zengdexing intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT wanghaichao intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT bartlettdavidl intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT billiartimothyr intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT zehherbertj intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT lotzemichaelt intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer AT tangdaolin intracellularhmgb1asanoveltumorsuppressorofpancreaticcancer |